Works matching DE "UNITED States. Congress. House. Committee on Oversight %26 Government Reform"


Results: 12
    1

    FDA Preemption.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 300, n. 22, p. 2599, doi. 10.1001/jama.2008.751
    By:
    • Mitka, Mike
    Publication type:
    Article
    2

    Redundant Drug Benefits.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 300, n. 2, p. 160, doi. 10.1001/jama.300.2.160-d
    By:
    • Mitka, Mike
    Publication type:
    Article
    3

    Surge Capacity.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 22, p. 2620, doi. 10.1001/jama.299.22.2620-b
    By:
    • Mitka, Mike
    Publication type:
    Article
    4

    Lead Paint Rule Criticized.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 18, p. 2141, doi. 10.1001/jama.299.18.2141-c
    By:
    • Mitka, Mike
    Publication type:
    Article
    5

    Subpoenas Refused.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 10, p. 1124, doi. 10.1001/jama.299.10.1124-c
    By:
    • Mitka, Mike
    Publication type:
    Article
    6

    Plant Inspections Lag.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 10, p. 1124, doi. 10.1001/jama.299.10.1124-a
    By:
    • Mitka, Mike
    Publication type:
    Article
    7
    8
    9
    10
    11

    Incentives for New Antibiotics.

    Published in:
    JAMA: Journal of the American Medical Association, 2012, v. 308, n. 6, p. 558, doi. 10.1001/jama.2012.9558
    By:
    • Mitka, Mike
    Publication type:
    Article
    12

    FDA Role in Drug Shortages.

    Published in:
    JAMA: Journal of the American Medical Association, 2012, v. 308, n. 6, p. 558, doi. 10.1001/jama.2012.8914
    By:
    • Mitka, Mike
    Publication type:
    Article